Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
================================================================================================================================================================================================

* Clémence Demerlé
* Laurent Gorvel
* Marielle Mello
* Sonia Pastor
* Clara Degos
* Ana Zarubica
* Fabien Angelis
* Frédéric Fiore
* Jacques A Nunes
* Bernard Malissen
* Laurent Greillier
* Geoffrey Guittard
* Hervé Luche
* Fabrice Barlesi
* Daniel Olive